Bright Green Corporation (BGXX)
USD 0.04
(0.0%)
USD 0.04
(0.0%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 17.4 Million USD | -23.63% |
| 2022 | 22.78 Million USD | 159.53% |
| 2021 | 8.78 Million USD | 11.14% |
| 2020 | 7.9 Million USD | -8.76% |
| 2019 | 8.65 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 15.98 Million USD | 0.16% |
| 2024 Q1 | 15.95 Million USD | -8.31% |
| 2023 Q3 | 24.33 Million USD | -2.21% |
| 2023 FY | 17.4 Million USD | -23.63% |
| 2023 Q4 | 17.4 Million USD | -28.49% |
| 2023 Q2 | 24.88 Million USD | 2.97% |
| 2023 Q1 | 24.16 Million USD | 6.06% |
| 2022 Q2 | 9.84 Million USD | 12.75% |
| 2022 Q1 | 8.72 Million USD | -0.59% |
| 2022 FY | 22.78 Million USD | 159.53% |
| 2022 Q4 | 22.78 Million USD | 26.61% |
| 2022 Q3 | 17.99 Million USD | 82.88% |
| 2021 FY | 8.78 Million USD | 11.14% |
| 2021 Q2 | 8.8 Million USD | 0.0% |
| 2021 Q4 | 8.78 Million USD | 1.1% |
| 2021 Q3 | 8.68 Million USD | -1.35% |
| 2021 Q1 | - USD | -100.0% |
| 2020 Q4 | 7.9 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 7.9 Million USD | -8.76% |
| 2019 FY | 8.65 Million USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Esperion Therapeutics, Inc. | 205.79 Million USD | 91.544% |
| ANI Pharmaceuticals, Inc. | 904.42 Million USD | 98.076% |
| Aquestive Therapeutics, Inc. | 57.41 Million USD | 69.691% |
| Collegium Pharmaceutical, Inc. | 1.14 Billion USD | 98.478% |
| Cosmos Health Inc. | 66.29 Million USD | 73.749% |
| Journey Medical Corporation | 76.84 Million USD | 77.354% |
| Dynavax Technologies Corporation | 997.09 Million USD | 98.255% |
| Embecta Corp. | 1.21 Billion USD | 98.567% |
| Intra-Cellular Therapies, Inc. | 728.29 Million USD | 97.61% |
| Pacira BioSciences, Inc. | 1.57 Billion USD | 98.895% |
| PainReform Ltd. | 9.93 Million USD | -75.257% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | 36.362% |
| Sunshine Biopharma, Inc. | 27.34 Million USD | 36.362% |
| SCYNEXIS, Inc. | 128.41 Million USD | 86.447% |
| Safety Shot Inc | 12.7 Million USD | -36.933% |
| China SXT Pharmaceuticals, Inc. | 23.12 Million USD | 24.75% |
| Alpha Teknova, Inc. | 128.58 Million USD | 86.466% |
| Procaps Group, S.A. | 460.18 Million USD | 96.218% |
| Theratechnologies Inc. | 77.76 Million USD | 77.622% |
| Harrow Health, Inc. | 311.75 Million USD | 94.418% |
| Sonoma Pharmaceuticals, Inc. | 14.89 Million USD | -16.854% |
| Biofrontera Inc. | 27.93 Million USD | 37.695% |
| DURECT Corporation | 45.18 Million USD | 61.488% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | 98.765% |
| Cronos Group Inc. | 1.13 Billion USD | 98.466% |
| OptiNose, Inc. | 107.72 Million USD | 83.846% |
| Ironwood Pharmaceuticals, Inc. | 471.07 Million USD | 96.306% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | 68.895% |
| RedHill Biopharma Ltd. | 23.04 Million USD | 24.489% |
| Organogenesis Holdings Inc. | 460.02 Million USD | 96.217% |
| Guardion Health Sciences, Inc. | 11.91 Million USD | -46.021% |
| Cumberland Pharmaceuticals Inc. | 81.77 Million USD | 78.719% |
| Radius Health, Inc. | 1.71 Billion USD | 98.986% |
| Universe Pharmaceuticals INC | 53.28 Million USD | 67.341% |
| ProPhase Labs, Inc. | 91.92 Million USD | 81.069% |
| Phibro Animal Health Corporation | 982.18 Million USD | 98.228% |
| Procaps Group S.A. | 460.18 Million USD | 96.218% |
| Alvotech | 950.09 Million USD | 98.168% |
| TherapeuticsMD, Inc. | 43.3 Million USD | 59.817% |
| Viatris Inc. | 47.68 Billion USD | 99.964% |
| Rockwell Medical, Inc. | 52.17 Million USD | 66.644% |
| Aytu BioPharma, Inc. | 118.09 Million USD | 85.264% |
| SIGA Technologies, Inc. | 254.83 Million USD | 93.171% |
| Tilray Brands, Inc. | 4.33 Billion USD | 99.599% |
| Lifecore Biomedical, Inc. | 273.7 Million USD | 93.642% |
| Shineco, Inc. | 84.17 Million USD | 79.326% |
| PetIQ, Inc. | 868.22 Million USD | 97.996% |
| Regencell Bioscience Holdings Limited | 8.43 Million USD | -106.241% |
| Incannex Healthcare Limited | 17.04 Million USD | -2.089% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | 99.465% |
| Alimera Sciences, Inc. | 153.52 Million USD | 88.664% |
| Silver Spike Investment Corp. | 88.57 Million USD | 80.352% |
| Assertio Holdings, Inc. | 286.41 Million USD | 93.924% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.95 Million USD | -192.403% |
| Petros Pharmaceuticals, Inc. | 33.79 Million USD | 48.505% |
| Clever Leaves Holdings Inc. | 31.24 Million USD | 44.298% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -31.368% |
| Avadel Pharmaceuticals plc | 261.12 Million USD | 93.335% |
| Hempacco Co., Inc. | 18.04 Million USD | 3.547% |
| Talphera, Inc. | 20.39 Million USD | 14.67% |
| Alvotech | 950.09 Million USD | 98.168% |
| Eagle Pharmaceuticals, Inc. | 406.16 Million USD | 95.715% |
| Lantheus Holdings, Inc. | 1.65 Billion USD | 98.946% |
| Currenc Group, Inc. | 141.49 Million USD | 87.7% |
| Kamada Ltd. | 351.96 Million USD | 95.056% |
| Indivior PLC | 1.95 Billion USD | 99.108% |
| Evoke Pharma, Inc. | 7.06 Million USD | -146.204% |
| Flora Growth Corp. | 23.62 Million USD | 26.339% |
| Cyclo Therapeutics, Inc. | 13.24 Million USD | -31.368% |
| Evolus, Inc. | 188.99 Million USD | 90.792% |
| HUTCHMED (China) Limited | 1.27 Billion USD | 98.64% |
| Amphastar Pharmaceuticals, Inc. | 1.51 Billion USD | 98.85% |
| Akanda Corp. | 8.83 Million USD | -96.867% |